CO5590899A2 - Combinacion farmaceutica - Google Patents

Combinacion farmaceutica

Info

Publication number
CO5590899A2
CO5590899A2 CO04052217A CO04052217A CO5590899A2 CO 5590899 A2 CO5590899 A2 CO 5590899A2 CO 04052217 A CO04052217 A CO 04052217A CO 04052217 A CO04052217 A CO 04052217A CO 5590899 A2 CO5590899 A2 CO 5590899A2
Authority
CO
Colombia
Prior art keywords
alkyl
cycloalkyl
alkenyl
group
groups
Prior art date
Application number
CO04052217A
Other languages
English (en)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CO5590899A2 publication Critical patent/CO5590899A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

1.- Una combinación inhalada de (a) un inhibidor selectivo de PDE4 de fórmula: o una de sus sales o solvatos farmacéuticamente aceptables, en la que R1 es H, alquilo C1-C6, alcoxi C1-C6, alquenilo C2-C4, fenilo, -N(CH3)2, cicloalquilo C3-C6, (cicloalquil C3-C6) (alquilo C1-C3) o acilo C1-C6, pudiendo estar los grupos alquilo, fenilo o alquenilo sustituidos con hasta dos grupos -OH, alquilo C1-C3 o -CF3 o con hasta tres halógenos;cada uno de R2 y R3 se selecciona independientemente del grupo formado por H, alquilo C1-C14, (alcoxi C1-C7) (alquilo C1-C7), alquenilo C2-C14, cicloalquilo C3-C7, (cicloalquil C3-C7) (alquilo C1-C2), un grupo (heterocíclico C4-C7) (CH2)n saturado o insaturado en el que n es 0, 1 ó 2, que contiene como heteroátomo uno o más del grupo formado por oxígeno, azufre, sulfonilo, nitrógeno y NR4, siendo R4 H o alquilo C1-C4; o un grupo de Fórmula (II): en la que a es un número entero de 1 a 5; b y c son 0 ó 1; R5 es H, -OH, alquilo C1-C5, alquenilo C2-C5, alcoxi C1-C5, cicloalcoxi C3-C6, halógeno, -CF3, -CO2R6, -CONR6R7,-NR6R7, -NO2 o -SO2NR6R7, siendo cada uno de R6 y R7 independientemente H o alquilo C1-C4; Z es -O-, -S-, -SO2-, -CO- o -N(R8) -, siendo R8 H o alquilo C1-C4; e Y es alquileno C1-C5 o alquenileno C2-C6, opcionalmente sustituido con hasta dos grupos alquilo C1-C7 o cicloalquilo C3-C7;pudiendo estar cada uno de los grupos alquilo, alquenilo, cicloalquilo, alcoxialquilo o heterociclico sustituidos con 1 a 14, preferiblemente 1 a 5 grupos alquilo C1-C2, CF3 o halo; y cada uno de R9 y R10 se selecciona independientemente del grupo formado por H, alquilo C1-C6, alcoxi C1-C6, arilo C6-C10 y ariloxi C6-C10;y (b) un agonista del receptor ß2-adrenérgico.
CO04052217A 2001-12-07 2004-06-04 Combinacion farmaceutica CO5590899A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination

Publications (1)

Publication Number Publication Date
CO5590899A2 true CO5590899A2 (es) 2005-12-30

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04052217A CO5590899A2 (es) 2001-12-07 2004-06-04 Combinacion farmaceutica

Country Status (33)

Country Link
US (2) US20030119862A1 (es)
EP (1) EP1455783A1 (es)
JP (1) JP2005511657A (es)
KR (1) KR20050044699A (es)
CN (1) CN1599609A (es)
AP (1) AP2004003054A0 (es)
AR (1) AR037712A1 (es)
AU (1) AU2002353255A1 (es)
BR (1) BR0214776A (es)
CA (1) CA2468676A1 (es)
CO (1) CO5590899A2 (es)
EA (1) EA200400640A1 (es)
EC (1) ECSP045142A (es)
GB (1) GB0129395D0 (es)
HN (1) HN2002000356A (es)
HR (1) HRP20040515A2 (es)
HU (1) HUP0402546A3 (es)
IL (1) IL162098A0 (es)
IS (1) IS7277A (es)
MA (1) MA27152A1 (es)
MX (1) MXPA04004930A (es)
NO (1) NO20042870L (es)
NZ (1) NZ533030A (es)
OA (1) OA12736A (es)
PA (1) PA8560601A1 (es)
PE (1) PE20031066A1 (es)
PL (1) PL370770A1 (es)
SV (1) SV2004001430A (es)
TN (1) TNSN04102A1 (es)
TW (1) TWI242433B (es)
UY (1) UY27564A1 (es)
WO (1) WO2003047578A1 (es)
ZA (1) ZA200403905B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (en) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Pharmaceutical composition that includes revamilast and a beta-2 agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0837860T3 (da) * 1995-06-06 2002-05-27 Pfizer Tricykliske 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo-[4,3-alfa]pyridiner
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
KR100701904B1 (ko) * 1999-08-21 2007-04-02 알타나 파마 아게 Pde 억제제 및 베타 2 아드레날린수용체 작동제의상승적 조합

Also Published As

Publication number Publication date
SV2004001430A (es) 2004-02-24
OA12736A (en) 2006-06-29
GB0129395D0 (en) 2002-01-30
HRP20040515A2 (en) 2004-10-31
ZA200403905B (en) 2005-06-22
IL162098A0 (en) 2005-11-20
HN2002000356A (es) 2003-02-21
WO2003047578A1 (en) 2003-06-12
TWI242433B (en) 2005-11-01
CN1599609A (zh) 2005-03-23
AR037712A1 (es) 2004-12-01
EA200400640A1 (ru) 2004-12-30
EP1455783A1 (en) 2004-09-15
TNSN04102A1 (fr) 2006-06-01
CA2468676A1 (en) 2003-06-12
NZ533030A (en) 2007-03-30
UY27564A1 (es) 2003-07-31
PA8560601A1 (es) 2005-02-04
AU2002353255A1 (en) 2003-06-17
HUP0402546A2 (hu) 2005-04-28
US20040167153A1 (en) 2004-08-26
KR20050044699A (ko) 2005-05-12
ECSP045142A (es) 2004-07-23
PL370770A1 (en) 2005-05-30
MA27152A1 (fr) 2005-01-03
BR0214776A (pt) 2004-11-09
JP2005511657A (ja) 2005-04-28
TW200300678A (en) 2003-06-16
AP2004003054A0 (en) 2004-06-30
IS7277A (is) 2004-05-21
HUP0402546A3 (en) 2008-04-28
PE20031066A1 (es) 2003-12-24
US20030119862A1 (en) 2003-06-26
MXPA04004930A (es) 2005-04-08
NO20042870L (no) 2004-07-06

Similar Documents

Publication Publication Date Title
CO5640041A2 (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
AR105103A1 (es) Derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen
AR055592A1 (es) Derivados de 2-amino-5-cicloalquil-hidantoina como moduladores y/o inhibidores de la beta-secretasa(bace)
AR082826A2 (es) Inhibidores heterociclicos de mek, composiciones farmaceuticas que los contienen, usos, y metodos de preparacion de los mismos
AR095192A1 (es) Quinolina y quinazolinamidas como modulares de canales de sodio
AR061739A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR053340A1 (es) Derivados de trifluormetilbenzamida y sus usos terapeuticos
AR058287A1 (es) Derivados de isoquinolina y composicion farmaceutica
AR037489A1 (es) Quinolinas sustituidas y proceso para su preparacion
CO5690579A2 (es) Derivados de diarilcicloalquilo, metodo para su produccion y su uso como medicamentos
AR044561A1 (es) Derivados de estatina
CO4900032A1 (es) Nuevos derivados de benzamidina
AR070263A1 (es) Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios.
AR094852A1 (es) Oestra-1,3,5(10),16-tetraeno-3-carboxamidas
AR066604A1 (es) Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente.
AR045155A1 (es) Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos
AR066605A1 (es) Derivados de heteroarilamida pirimidona
AR050153A1 (es) Beta-agonistas, procedimiento para su preparacion y su uso como medicamentos
AR057464A1 (es) Procedimiento para la preparacion de derivados de sulfonamida
AR047606A1 (es) 4-oxobenzonitrilos como moduladores de receptores de androgenos,composiciones farmaceuticas que los contienen y usos
AR046793A1 (es) Derivados de pirazol, antagonistas del receptor de la orexina
AR066603A1 (es) Derivados de arilamida pirimidona
AR054747A1 (es) Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
CO4700460A1 (es) 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS
AR042362A1 (es) Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen

Legal Events

Date Code Title Description
FC Application refused